United States: Pharmaceutical Companies Have Rights If The Federal Government Seized Their Patents - Sheppard Mullin Richter & Hampton

Credit: Mondaq- Published 2 weeks ago
The Biden administration recently determined that it has the right to seize patents covering certain high-priced medicines, in an apparent effort to take a more aggressive approach to lowering drug prices.
👓 View full article:  

You are here

› Legal › United States: Pharmaceutical Companies Have Rights If The Federal Government Seized Their Patents - Sheppard Mullin Richter & Hampton

Related videos from verified sources

Modern MK Ultra: Investigations w/ Bryanna & Fabian 04:04
Credit: Rumble - Published on March 29, 2024 


Related news from verified sources

United States: 6 Key Considerations For Selling Carbon Pollution-Free Electricity To The Federal Government - Sheppard Mullin Richter & Hampton
In line with the goals set forth in the Federal Government's Federal Sustainability Plan, the General Services Administration ("GSA") recently issued a Request...
1 week ago • Mondaq

United States: Better Safe Than Sorry: OMB Releases Memorandum On Managing AI Risks In The Federal Government - Sheppard Mullin Richter & Hampton
On March 28, 2024, the Office of Management and Budget ("OMB") issued Memorandum M-24-10, Advancing Governance, Innovation, and Risk Management for Agency Use of...
1 week ago • Mondaq

You might like

© 2024 newsR Ltd.
All Rights Reserved.

Contact us





Video

🔝 Scroll back up to the top

⌂ Home Page

Desktop version of this page:
🖥️ United States: Pharmaceutical Companies Have Rights If The Federal Government Seized Their Patents - Sheppard Mullin Richter & Hampton